MedTrace Logo

Molecular Markers in Treatment in Endometrial Cancer

NCT00598845 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2014-12-23

No results posted yet for this study

Summary

The purpose of this prospective multicenter trial is to investigate the value of molecular markers in endometrial cancer for predicting lymph node metastasis and prognosis in relation to treatment.

Conditions

  • Endometrial Neoplasms
  • Neoplasm Metastasis

Interventions

PROCEDURE

Tumor biopsy study

Tumor specimens from endometrial cancer patients, collected preoperatively and during primary hysterectomy, are investigated.

Sponsors & Collaborators

  • Helse-Bergen HF

    collaborator OTHER

  • Norwegian Cancer Society

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Helga B. Salvesen, Prof., MD, PhD · University of Bergen

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2015-12-31
Completion
2017-12-31

Countries

  • Belgium
  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00598845 on ClinicalTrials.gov